It is recommended to avoid nonsteroidal anti-inflammatory drugs (NSAIDs) in patients with hypertension, heart failure, or chronic kidney disease. This trial describes frequency of NSAID prescribing in these populations and looks to determine if there are short-term safety-related outcomes.

Read the Journal Scan